MyFinsight
Home
Blog
About
Contact
Proceeds from maturities
of investments
$30,000K
Net cash provided by
investing activities
$13,127K
Canceled cashflow
$16,873K
Net decrease in
cash, cash...
-$7,444K
Canceled cashflow
$13,127K
Stock-based compensation
expense
$2,181K
Depreciation expense
$383K
Prepaid expenses and
other current assets
-$380K
Non-cash operating lease
expense
$273K
Net amortization of
premiums and accretion of...
-$161K
Purchases of investments
$16,859K
Purchases of property and
equipment
$14K
Net cash used in
operating activities
-$20,538K
Canceled cashflow
$3,378K
Net cash used in
financing activities
-$33K
Net loss
-$19,042K
something is missing
-$2,872K
Accounts payable
-$1,202K
Accrued expenses and
other current...
-$506K
Operating lease
liabilities
-$294K
Payments of tax
withholdings related to...
$33K
Back
Back
Cash Flow
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)
source: myfinsight.com